Both in Pharmaceuticals
Ultragenyx Pharmaceutical vs Stoke Therapeutics
Over the past year RARE returned −49.9% and STOK returned −11.1%; their daily moves had a correlation of 0.20.
RARE −49.9% STOK −11.1%Growth of $1, one year, split-adjusted
| Metric | RARE | STOK |
|---|---|---|
| Price | $14.89 | $24.29 |
| Market cap | $1.47B | $1.57B |
| Today | +2.97% | −0.33% |
| 1 month | +0.1% | −19.2% |
| 6 months | −35.7% | −30.3% |
| Year to date | −35.3% | −23.5% |
| 1 year | −50.7% | −9.4% |
| Revenue growth (YoY) | +28.1% | −32.5% |
| Gross margin | 84.1% | 100.0% |
| Net margin | −43.0% | −660.8% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 56.8× |
| Net cash | $292.0M | $292.8M |
| Dividend yield | — | — |
| Volatility (60d) | 127.6% | 45.2% |
| Short % of float | 17.7% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).